Difference between revisions of "Patient Provided Data"
From Patient Determinants
| Line 1: | Line 1: | ||
| − | + | Cognitive Screening <br> | |
| + | * [http://www.mobihealthnews.com/content/verily-vet-board-mindstrong-health-gets-14m-quantify-mental-health-monitoring-smartphone Mindstrong is developing objective measures of brain function based on patterns of interaction with a smartphone. Digital biomarkers Mindstrong measures include processing speed, attention, memory and executive function. The company is led by former NIMH director Dr. Thomas Insel (6/19/17)] | ||
| + | * [http://www.imedicalapps.com/2017/03/cantab-mobile-fda/ FDA provided clearance for CANTAB Mobile app that helps screen for Alzheimer’s and cognitive impairment (3/1/17)] | ||
| + | * [http://www.imedicalapps.com/2017/02/new-neurocognitive-assessment-tool-available-smartphones/ Savonix developed a mobile, evidence-based neurocognitive assessment platform that eliminates the need for pen and paper exams that screen for cognitive functions. (2/2/17)] | ||
Health Risk Assessment <br> | Health Risk Assessment <br> | ||
* [http://medcitynews.com/2015/07/johnson-johnson-my-health-discovery-mobile-digital-health/ Health Risk Assessment - Johnson & Johnson’s new health risk assessment product aimed at improving user health by asking the right questions (7/20/15)] | * [http://medcitynews.com/2015/07/johnson-johnson-my-health-discovery-mobile-digital-health/ Health Risk Assessment - Johnson & Johnson’s new health risk assessment product aimed at improving user health by asking the right questions (7/20/15)] | ||
See [http://www.patientdeterminants.org/index.php?title=Digital_Health_Technology#Patient_Provided_Data Patient Provided Data Technology] | See [http://www.patientdeterminants.org/index.php?title=Digital_Health_Technology#Patient_Provided_Data Patient Provided Data Technology] | ||
Revision as of 15:57, 30 March 2018
Cognitive Screening
- Mindstrong is developing objective measures of brain function based on patterns of interaction with a smartphone. Digital biomarkers Mindstrong measures include processing speed, attention, memory and executive function. The company is led by former NIMH director Dr. Thomas Insel (6/19/17)
- FDA provided clearance for CANTAB Mobile app that helps screen for Alzheimer’s and cognitive impairment (3/1/17)
- Savonix developed a mobile, evidence-based neurocognitive assessment platform that eliminates the need for pen and paper exams that screen for cognitive functions. (2/2/17)
Health Risk Assessment
